Multiple Sclerosis
Conference Coverage
The case for being open-minded about medical marijuana
LAS VEGAS – As part of an open approach, educate patients about effective alternative treatments to medical cannabis, an expert advises.
Article
MS Medication Withdrawn Because of Safety Concerns
Citing concerns about safety, Biogen and AbbVie announced March 2 that they will be withdrawing daclizumab (Zinbryta) from worldwide markets....
Conference Coverage
Alemtuzumab-induced autoimmunity: getting closer to answers
Researchers are getting closer to identifying MS patients more susceptible to secondary autoimmunity after alemtuzumab treatment.
Latest News
MS medication withdrawn because of safety concerns
Daclizumab had known risks, but reports of adverse events led the European Medicines Agency to investigate.
Conference Coverage
Does Vitamin D Level Affect Progressive MS?
SAN DIEGO—Vitamin D levels may be associated with brain imaging measures in patients with progressive multiple sclerosis (MS), according to an...
Conference Coverage
High dose of novel compound for relapsing-remitting MS shows promise
SAN DIEGO – Evidence of remyelination observed at 24 weeks.
Conference Coverage
How Are Newer DMTs Used in Pediatric MS?
SAN DIEGO—Newer oral and IV disease-modifying therapies (DMTs) for multiple sclerosis (MS) increasingly are used in children, according to data...
Conference Coverage
Can Online Patient Journals Improve MS Care?
SAN DIEGO—Continuous collection of patient-reported outcomes via a web-based platform may help neurologists identify patients with multiple...
Conference Coverage
Health Care Use May Elucidate MS Prodrome
SAN DIEGO—In the five years before multiple sclerosis (MS) symptom onset, patients are more likely to see a physician or be admitted to the...
Conference Coverage
Researchers find predictors of worse MS outcomes in post hoc study of three trials
Predicting which people with MS might experience relapse or progression of disability could help clinicians more closely follow those at higher...
Literature Review
ECTRIMS and EAN Publish Recommendations for Treating MS
The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and the European Academy of Neurology (EAN) have published a...